BOSTON (WBZ NewsRadio) — A new study revealed that the Moderna COVID-19 vaccine is 96% effective among children ages 12-17.
The study included more than 3,200 participants who received at least one dose of the vaccine.
Moderna announced its findings on Thursday in its first quarter earnings report.
The Cambridge-based biotech company said that so far, the vaccine has been "well tolerated with no serious safety concerns."
Moderna is currently studying the efficacy of the vaccine on children ages 6 months to 11 years old; there are no further details at this time.
WBZ NewsRadio's Laurie Kirby (@LaurieWBZ) reports: